Dashboard MRSA
Repurposing candidates for MRSA
Methicillin-resistant Staphylococcus aureus
Approved medicines with AI-predicted activity ≥40% against MRSA, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 860
- Existing antimicrobials set aside
- 117
- Needing review
- 72
- Repurposing candidates
- 671
Repurposing candidates for MRSA
AI prediction · nothing measuredAll 671 repurposing candidates for MRSA.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Pipecuronium BromideExisting use: Other quaternary ammonium compounds56.6% AI-predicted activityagainst MRSA5 registered studies
- PimecrolimusExisting use: Atopic eczema, Eczematoid dermatitis56.5% AI-predicted activityagainst MRSA50+ registered studies
- DacomitinibExisting use: Neoplasm, Non-small cell lung carcinoma56.4% AI-predicted activityagainst MRSA50+ registered studies
- LovastatinExisting use: Atherosclerosis, Cardiovascular disease, Coronary artery disease and 2 more56.4% AI-predicted activityagainst MRSA50+ registered studies
- AtogepantExisting use: Migraine disorder56.4% AI-predicted activityagainst MRSA36 registered studies
- TafamidisExisting use: AL amyloidosis, Amyloidosis, Cardiomyopathy56.4% AI-predicted activityagainst MRSA50+ registered studies
- LurbinectedinExisting use: Cancer, Neoplasm, Small cell lung carcinoma56.3% AI-predicted activityagainst MRSA50+ registered studies
- Tubocurarine ChlorideExisting use: Curare alkaloids56.3% AI-predicted activityagainst MRSANo documented evidence found
- AprepitantExisting use: Cancer, Chemotherapy-induced nausea and vomiting, Nausea and 3 more56.3% AI-predicted activityagainst MRSA50+ registered studies
- RescinnamineExisting use: Hypertension56.3% AI-predicted activityagainst MRSANo documented evidence found
- GefitinibExisting use: Cancer, Neoplasm, Non-small cell lung carcinoma56.2% AI-predicted activityagainst MRSA50+ registered studies
- TerconazoleExisting use: Triazole derivatives56.2% AI-predicted activityagainst MRSA10 registered studies
- Betamethasone Sodium PhosphateExisting use: Airway obstruction, Eye inflammation, Hemorrhoid and 2 more56.2% AI-predicted activityagainst MRSA50+ registered studies
- Dexamethasone Sodium PhosphateExisting use: Acne, Adrenal gland disease, Adrenal gland hyperfunction and 79 more56.2% AI-predicted activityagainst MRSA50+ registered studies
- Candesartan CilexetilExisting use: Angina pectoris, Congestive heart failure, Diabetes mellitus and 4 more56.1% AI-predicted activityagainst MRSA50+ registered studies
- Estradiol CypionateExisting use: Atrophic Vaginitis, Atrophy, Breast cancer and 10 more56.1% AI-predicted activityagainst MRSA50+ registered studies
- Mobocertinib SuccinateExisting use: Neoplasm, Non-small cell lung carcinoma56.1% AI-predicted activityagainst MRSANo documented evidence found
- Cobimetinib FumarateExisting use: Cancer, Melanoma, Metastatic melanoma and 1 more56.1% AI-predicted activityagainst MRSANo documented evidence found
- ReserpineExisting use: Hypertension56.0% AI-predicted activityagainst MRSA10 registered studies
- Cisapride MonohydrateExisting use: Gastrointestinal disease56.0% AI-predicted activityagainst MRSA5 registered studies
- OteseconazoleExisting use: Vulvovaginal candidiasis55.9% AI-predicted activityagainst MRSA6 registered studies
- BudesonideExisting use: Airway obstruction, Allergic rhinitis, Asthma and 10 more55.8% AI-predicted activityagainst MRSA50+ registered studies
- Bromocriptine MesylateExisting use: Acromegaly, Adenoma, Hyperprolactinemia and 4 more55.7% AI-predicted activityagainst MRSA50+ registered studies
- SiponimodExisting use: Multiple sclerosis55.7% AI-predicted activityagainst MRSA33 registered studies